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Congenital insensitivity to pain with anhidrosis (CIPA; MIM 256800) is an autosomal-
recessive disorder characterized by recurrent episodes of unexplained fever, anhidrosis 
(absence of sweating) and absence of reaction to noxious stimuli, self-mutilating 
behavior and mental retardation1-3. The genetic basis for CIPA is unknown. Nerve 
growth factor (NGF) induces neurite outgrowth and promotes survival of embryonic 
sensory and sympathetic neurons4. Mice lacking the gene for TrkA, a receptor tyrosine 
kinase for NGF5,6, share dramatic phenotypic features of CIPA, including loss of 
responses to painful stimuli, although anhidrosis is not apparent in these animals7. We 
therefore considered the human TRKA homologue as a candidate for the CIPA gene. 
The mRNA and genomic DNA encoding TRKA were analyzed in three unrelated CIPA 
patients who had consanguineous parents. We detected a deletion-, splice- and a 
missense-mutation in the tyrosine kinase domain in these three patients. Our findings 
strongly suggest that defects in TRKA cause CIPA and that NGF-TRKA system has a 
crucial role in the development and function of the nociceptive reception as well as 
establishment of thermoregulation via sweating in humans. These results also implicate 
genes encoding other TRK and neurotrophin family members as candidates for 
developmental defect(s) of the nervous system. 
 
CIPA is also known as congenital sensory neuropathy with anhidrosis or hereditary 
sensory and autonomic neuropathy type IV1-3. The defects of pain and temperature 
sensations in CIPA are probably due to an almost complete absence of the first-order afferent 
system generally considered responsible for pain and temperature sensation1,8. A genetically 
determined defect in differentiation and migration of neural crest elements early in 
embryogenesis has been postulated to be the cause of this disease8,9, following the 
pioneering work by Levi-Montalcini4. Electron microscopy studies reveal complete absence 
of small myelinated and unmyelinated fibers10. Sweat glands on skin biopsy in CIPA 
appeared to be normal, but an ultrastructural study of skin biopsies reveal noninnervation of 
eccrine sweat glands11. In TrkA-deficient mice, virtually all dorsal root ganglia (DRG) 
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neurons associated with nociceptive functions are lost7. They also have extensive neuronal 
cell loss in sympathetic ganglia and a decrease in cholinergic neurons of the basal forebrain.  
We examined three candidate genes initially: NGF, p75 neurotrophin receptor (see below), 
and TRKA. To facilitate detection of putative TRKA mutations, we selected three unrelated 
CIPA patients who had consanguineous parents, and in which homozygous abnormalities 
could be expected (see Methods). Given the lack of information on the whole human TRKA 
gene, we determined part of the gene structure (Fig. 1). Preliminary data shows that TRKA is 
expressed in EB-virus transformed lymphoblastoid cells. Thus, RNA from these cell lines 
from CIPA-affected individuals could be used to assess this locus as a candidate for CIPA.  
A single base C at nucleotide 1726 was deleted in exon C of the first patient (KI-01) (Fig. 
2a). This deletion occurs in a region encoding the tyrosine kinase domain, causing a 
frameshift and premature termination codons downstream. The proband and her parents were 
homozygous and heterozygous for the 1726-C deletion, respectively (Fig. 2b; data not 
shown). RT-PCR analysis revealed a shorter-than-expected band in KI-01, which upon 
sequencing showed a deletion of 451 nucleotides, from 1421 to 1871 encompassing exons A, 
B and C (data not shown). We amplified and sequenced all three exons and flanking exon-
intron junctions from genomic DNA, but found no abnormalities in these boundaries. The 
transcript lacking exons A – C was also observed in the two patients described below. Thus, 
it could be a product of alternative splicing which occurs rarely in lymphoblastoid cells. This 
alternative transcript in the patient was detected in part because of its shorter size and 
because of the instability of the normal-size transcript containing the single base deletion. 
Thus, the 1726-C deletion is apparently the cause of CIPA in this family. 
In an Ecuadorian family, two small fragments were amplified from a proband (GM 08382) 
and his affected brother (GM 08383) by RT-PCR, although a single product was amplified 
from a control (Fig. 2d). The parents yielded three fragments, including two small ones 
observed for the proband and a normal sized band. Two small cDNA fragments from this 
patient were subcloned and sequenced. Deletions were found to correspond to an exon (1872-
2112) (D in Fig. 1) and part of the same exon (1966-2112) on the other allele, indicating the 
presence of RNA splicing errors. The partial exon deletion is apparently due to activation of 
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a cryptic splice donor site. Sequencing of genomic DNA revealed that the 5’ splice site of an 
intron between exons D and E contains a C for A substitution in the third position (Fig. 2c). 
Similar mutations at the third position of the intron resulted in skipping of the preceding 
exon12. No substitution was found in exon D and the flanking exon-intron junctions. 
Restriction digestion analysis demonstrated that GM 08382 and GM 08383 were 
homozygous for the A - C transversion and that parents were heterozygous (Fig. 2e). The 
mutation was not detected in genomic DNAs from 50 control subjects (data not shown).  
In the third patient (KI-02), we found a G - C transversion at nucleotide 1795 in exon C, 
which causes a Gly-to-Arg substitution at amino acid 571 (Fig. 2f). Following amplification 
of exon C from parental genomic DNA, we detected both mutant and wild-type alleles (data 
not shown). Restriction digestion analysis showed that the patient and parents were 
homozygous and heterozygous for this mutation, respectively (Fig. 2g), whereas the mutation 
was not detected in genomic DNAs from 50 control subjects (data not shown). Gly 571 is 
located in the tyrosine kinase domain and is conserved among 14 receptor tyrosine kinases, 
including human TRKB and TRKC (Fig. 3), suggesting that it is important for enzyme 
activity. The Gly-to-Arg substitution is likely to be the cause of CIPA in this family. 
We have also studied two other potential candidate genes for CIPA, NGF itself, and the 
p75 neurotrophin receptor, based on the similar phenotypes in the respective knockout 
mice13,14. We did not detect mutation in these genes in an unrelated CIPA patient from non-
consanguineous parents.  
Anatomical changes in the DRG neurons and spinal cord in TrkA-deficient animals are 
similar to those noted in CIPA, including absence of small neurons in the DRG, lack of small 
fibers in the dorsal roots, absence of Lissauer’s tract and reduction of the spinal tract of the 
trigeminal nerve8. Miotic pupils and slight ptosis associated with loss of neurons in the 
superior cervical ganglia are the features in these mice, suggesting a defect in sympathetic 
innervations7. These are not common findings in CIPA, but have been reported in some 
patients9. Why CIPA patients with the same apparent gene disruption do not show a 
deficiency in sympathetic innervations will need to be addressed. This could be due to 
species differences or alternatively, sympathetic innervations in humans might be maintained 
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or compensated for by a combination of other neurotrophin and receptor systems. The 
autonomic ganglia and brain appeared normal in a patient with CIPA8, but additional 
pathological studies on CIPA patients are required, including analysis of these ganglia as 
well as the central nervous system sites of TRKA expression in humans15,16.   
A characteristic feature in CIPA is anhidrosis. Sweating is important to maintain body 
temperature under hot environmental conditions, especially in humans17. Eccrine sweat 
glands are innervated by sympathetic cholinergic fibers originating from the paravertebral 
ganglia, although the great majority of the post-ganglionic sympathetic fibers are 
adrenergic18. Noninnervation of eccrine sweat glands seems to be main cause of anhidrosis 
observed in CIPA11. Another possibility is that a mechanism controlling body temperature 
homeostasis does not function properly since input of temperature sensation from the 
peripheral nervous system is disturbed due to a loss of specific neurons. Eccrine glands are 
well developed in humans, but are limited to the underside of paws in mice and rats19. 
Rodents probably maintain body temperature by panting or saliva-spreading. Differences in 
mechanisms of temperature homeostasis might be one reason why unexplained fever is a 
prominent feature in CIPA. Almost 20% of the reported patients died from hyperpyrexia 
within the first 3 years of life20. Interestingly, about half of the TrkA knockout mice died 
within 20 days of life7, but their body temperature homeostasis requires further study. 
Mutations of the TRKA gene in CIPA patients suggest that TRKA is essential for innervation 
of eccrine glands by sympathetic neurons. Thus, the NGF-TRKA system probably plays a 
crucial role in development and function of the nociceptive reception as well as 
establishment of thermoregulation via sweating systems in humans. Genetic diseases caused 
by a loss of function of either neurotrophin and TRK families have not been described 
previously in humans, although TRKA was originally cloned as part of the TRK oncogene, a 
chimaeric transforming gene21. Our results implicate genes encoding other member(s) of 
these families as candidates for developmental defect(s) of the nervous system. 
 Note added in proof: We have recently discovered that a fourth patient (see Methods) is 
homozygous for the same single-base deletion in exon C as patient KI-01.
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Methods 
Subjects.  
In the Ecuadorian family, the proband (GM08382) was a male with frequent episodes of 
unexplained fever, anhidrosis, self-mutilating behavior and mental retardation. Abnormal 
findings on the histamine test and sural nerve biopsy were reported22. He has a similarly 
affected brother (GM08383) and parents (GM08384 and GM08385A). In the other two 
families, the probands, KI-01 and KI-02 were females born to Japanese parents with clinical 
similar symptoms. Lymphoblastoid cell lines from the Ecuadorian family were obtained from 
the Coriell Cell Repository (Camden, NJ). Establishment of lymphoblastoid cell lines from 
other patients was described23.  
  We also screened two other CIPA patients, from non-consanguineous parents; RT-PCR 
from both patients revealed abnormally sized bands, and we have preliminary evidence for 
compound heterozygous TRKA mutations in one of them. Complete analysis was hampered 
by lack of a full-length gene, hence these results are not considered further in this paper. 
 
Exon-intron junctions of TRKA. 
A human genomic library was screened with human TRKA cDNA24. One positive genomic 
clone was isolated. This clone covered the genomic region corresponding to 1/3 of the 3’-end 
cDNA sequence. The genomic region corresponding to the cDNA sequence 935-1688 was 
reported25. Taken together, exon-intron junctions of the TRKA gene encoding the 
intracellular domain of TRKA were determined. 
 
Primers.  
Sequences of forward and reverse primers for TRKA cDNA24 are as follows:  
Forward primers:  
U-1250 5’-ACCCCATCCCTGACACTAAC-3’;  
U1291 5’-GAGAAGAAGGACGAAACACC-3’;  
U-1339 5’-GCCGTCTTTGCCTGCCTCTT-3’;  
U-1452 5’-GGCCATGTCCCTGCATTTCA-3’;  
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U-1638 5’-CTTCCTTGCTGAGTGCCACA-3’;  
U-1850 5’-GGGACCTCAACCGCTTCCTC-3’;  
U-2091 5’-CTACAGCACCGACTATTACC-3’;  
Int-2 5’-CCAGTCTCCTCTCCCATCAC-3’;  
Int-3 5’-TCCTGTCCCTGCCGCTTCCA-3’. 
Reverse primers:  
L-1547 5’-GGCATCACTGAAGTATTGTG-3’;  
L-1680 5’-CCTTGACAGCCACCAGCATC-3’;  
L-1705 5’-GCACTCTCGGACGCCTCCTT-3’;  
L-1895 5’-ATCCTCCCCACCAGCCAGCA-3’;  
L-2059 5’-ATGCCAAAATCACCAATCTT-3’;  
L-2170 5’-CTCTCGGTGGTGAACTTACG-3’;  
L-2475 5’-ATTCCGGCTAACCACTCCCA-3’;  
L-2578 5’-AGCCCCCACCTGTCCCTTCC-3’;  
Int-1 5’-CTATGTTCACACATCTGCCT-3’. 
Primers, Int-1, Int-2 and Int-3 were designed according to the intronic sequences.  
 
RT-PCR. 
Total RNA was extracted from EB-virus transformed lymphoblastoid cells26. The first-strand 
cDNAs were generated from 10 μg of total cellular RNA with 5 pmol of random hexamer, 
using 200 U of MMLV virus reverse transcriptase (GIBCO BRL) in 20 μl of reaction 
mixture. PCR was carried out, using 2 μl of the first-strand cDNA as a template and 0.5 μM 
of each of the primers (U-1250/L-2170 and U-1638/L-2578). Subsequently, products of the 
first PCR were used as template for a second PCR with U-1291/L-2059 and U-1850/L-2475. 
The amplification conditions were as follows: 35 cycles of denaturation at 94 °C for 1 min, 
annealing at 55 °C for 1 min, and extension at 72 °C for 2 min. 
 
Amplification of genomic DNA. 
Genomic DNAs were prepared from lymphoblastoid cells by standard methods27. 
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Amplification of exon-intron junction from genomic DNA was performed by following sets 
of primers located in consecutive exons (Fig. 1). Approximate size of each product, including 
an intron, is shown in parenthesis. These are U-1339/L-1547 (750 bp), U-1452/L-1680 (650 
bp), U-1638/L-1705 (270 bp), and U-2091/L-2170 (750), generating corresponding exon-
intron junction sequences. Sets of primers U-1850/L-Int 1 (210 bp) and Int-2/L-1895 (140 
bp), respectively, were used for amplification of two exon-intron junctions between exons C 
and D. 
 
Cloning and sequencing of PCR products. 
Amplified PCR products were cloned into the T-vector28. The plasmid vector, pBluescript 
KS (+ ) ( Stratagene ), was digested with EcoRV, treated with Taq polymerase. Each clone 
was sequenced by a DNA Sequencer, GENESCAN Model 373A and Taq Dye Deoxy 
Terminator Cycle Sequencing Kit (Applied Biosystems Inc.). Mutations were detected by 
comparing the cloned sequence with the published cDNA and genomic sequence or normal 
control sequence and confirmed if multiple clones had the same base change. A primer set of 
U-2091 / L-2170 was used for sequence analysis of genomic DNA from GM 08382. For 
sequence analysis of KI-01 and KI-02, Exon C was amplified from genomic DNA with a 
primer set of Int-3 / Int-1.  
 
Restriction digestion analysis. 
For analysis of KI-01, genomic DNA was amplified with the same set of primers as 
described for KI-02 (see below), digested with Bsp1286I and electrophoresed. Conditions for 
PCR are described above. For analysis of GM 08382, a reverse primer, GM-82, was 5’-
CAGGGGAAGGCGTTGGGGACAAAGGCAGCT-3’ and complementary to bases +4 - 
+33 of the intron. Three bases underlined were modified from ACC to CAG to introduce 
PvuII site into the amplified mutant allele. First, DNA fragments were amplified with a 
primer set of Int-2/L-2170 or U-2091/L-2170, then were used as template for a second PCR 
with U-2091/GM-82, generating 55 bp product. Conditions for PCR are described above. 
The products were incubated with 10 U of PvuII and electrophoresed on 4% Nusieve agarose 
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gel (FMC BioProducts). For analysis of KI-02, a forward intronic primer (Int-3) and a 
reverse primer (Ue-L1796), modified to introduce SacII site in mutated allele, were used to 
amplify a PCR product from genomic DNA. SacII was added to each of the products, and 
fragments were subsequently resolved. 
 (Ue-L1796: 5'-TGAGCAGGGGGCGGCCCTCGGTGCAGCCGC-3' The underlined base 
was modified to introduce the SacII site into the mutated allele.) 
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Figures. 
 
Fig. 1 Human gene and cDNA encoding intracellular domain of TRKA. 
 
 
 
Fig. 1 Human gene and cDNA encoding intracellular domain of TRKA.  
The open boxes (A-F) represent 6 exons encoding the intracellular domain. The shaded box 
shows the 3’-noncoding region. The dotted line is an interrupted intron. Numbers above the 
cDNA boxes indicate the 3’-end of each exon, according to the published sequence24. 
Arrows indicate forward and reverse primers used for PCR. The region corresponding to the 
tyrosine kinase domain (TK) is shown below the cDNA. 
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Fig. 2 Detection of TRKA mutations in congenital insensitivity to pain with anhidrosis. 
 
Fig. 2a  
Sequence analysis of exon C amplified from genomic DNA of KI-01. 
 
 
 
Fig. 2 Detection of TRKA mutations in congenital insensitivity to pain with anhidrosis. 
Fig. 2a, Sequence analysis of exon C amplified from genomic DNA of KI-01.  
A single base C at nucleotide 1726 is deleted, causing a frameshift and premature termination 
codon downstream.  
 14 
Fig. 2b  
Restriction digestion analysis of the genomic region around the mutation in family 
members of KI-01. 
 
 
 
Fig. 2b, Restriction digestion analysis of the genomic region around the mutation in family 
members of KI-01.  
PCR products of 152bp were digested with Bsp1286I and electrophoresed on a 4% agarose 
gel. The symbols (+) and (-) denote presence and absence of the enzyme for incubation, 
respectively. There is a Bsp1286I site in the normal control sequence, providing fragments of 
102 and 50 bp (lane 1). The single base deletion at nucleotide 1726 disrupts this site, 
preventing digestion. Analysis of the PCR product for each individual is shown below the 
corresponding symbols in the pedigree.  
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Fig. 2c A - C mutation in TRKA from Ecuadorian patient GM08382. 
 
 
 
Fig. 2c, A - C mutation in TRKA from Ecuadorian patient GM08382.  
The sequence of the 5’ splice site of an intron between exon D and E contains a point 
mutation substituting a C for A in the third position.   
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Fig. 2d 
Analysis of RT-PCR products from the Ecuadorian family. 
 
 
 
 
Fig. 2d, Analysis of RT-PCR products from the Ecuadorian family.  
A set of primers was used to amplify a product extending from part of the tyrosine kinase 
domain to the C terminus. A single RT-PCR product of 645 bp was amplified from a control 
(lane 1). In contrast, two small fragments with 498 and 404 bp were amplified from the 
proband, GM08382 (lane 2) and an affected brother, GM08383 (lane 3). Analysis of 
consanguineous parents, GM08384 (lane 4) and GM08385A (lane 5), show all three 
fragments.  
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Fig. 2e 
Restriction digestion analysis in the genomic region around the mutation in GM08382. 
 
 
 
Fig. 2e, Restriction digestion analysis in the genomic region around the mutation in 
GM08382.  
PCR products of 55 bp were digested with PvuII. There is no PvuII site in the normal control 
sequence (lane 1). However, the A-C transversion mutation creates a PvuII site, producing 
cleavage of fragments of 28 and 27 bp. (Resolution of these two bands was not apparent in 
the 4% agarose gel.) 
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Fig. 2f  
Sequence of the region around TRKA nucleotide 1795 of KI-02, demonstrating a G - C 
transversion (arrow) at this nucleotide. 
 
 
 
Fig. 2f, Sequence of the region around TRKA nucleotide 1795 of KI-02, demonstrating a G - 
C transversion (arrow) at this nucleotide.  
Exon C was amplified from genomic DNA and complementary sequences of control and KI-
02 are shown. The mutation changes codon GGC to CGC (Gly571Arg). 
 
 19 
Fig. 2g  
Restriction digestion analysis of the genomic region around the mutation of KI-02.  
 
 
 
Fig. 2g, Restriction digestion analysis of the genomic region around the mutation of KI-02.  
PCR products of 152bp were digested with SacII. A SacII site, absent in the normal control 
sequence (lane 1), is created by the G-C transversion at nucleotide 1795 results in fragments 
of 123 and 29 bp. Only the 123bp-fragments are shown.  
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Fig. 3 
Conservation of a mutated residue in TRKA in various growth factor receptors. 
 
 
 
Fig. 3 Conservation of a mutated residue in TRKA in various growth factor receptors.  
Shown is the region of the tyrosine kinase domain flanking Gly571, mutated in KI-02 
(alignment based on refs 24, 29). Uppercase indicates either identical or conserved residues. 
Lowercase indicates unrelated residues. Closed and open circles show residues shared by all 
receptors listed and conserved residues shared by at least 13 of the 14 receptors, respectively. 
Amino acid 565 to 573 were aligned with those corresponding to the homologous regions of 
the human cell surface receptor for TrkB, TrkC, insulin (IR), IGF-1 (IGF-IR), EGF, and 
CSF-1, the mouse PDGF receptor, products of the human homologue of the retroviral v-ros 
(c-ros ) and v-kit (c-kit ) oncogenes, those of the human ret and met proto-oncogene, the 
erbB2 and the eph gene. 
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